Plain-English translation of NCT06767813 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Neoplasms research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II clinical trial testing combined with chemotherapy and an oral medication called anlotinib for people with advanced pancreatic cancer. Researchers want to see if this new combination can slow or shrink tumors and how safe it is. You would receive the medication as part of a structured treatment plan with regular cycles.
Pancreatic cancer is very serious, and current first-line treatments don't work well enough for everyone. This trial is testing whether adding a new injectable medication to standard chemotherapy might help more patients live longer and have better outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive injections combined with chemotherapy pills and take an oral medication daily in cycles. In the initial treatment phase (28 days per cycle), you would receive multiple medications including the new injection and chemotherapy, plus oral tablets for 2 weeks followed by 1 week of rest. If your cancer responds, you would continue into a maintenance phase with a simpler regimen. You would have regular clinic visits and scans to monitor how well the treatment is working and manage any side effects.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China